It’s time to shine the light on direct-to-consumer advertising

Annals of Family Medicine

Volumn 13, Issue 1, 2015, Pages 82-85

  Mackey, Tim K ^a,b,c   Liang, Bryan A ^a,c  

^a Global Health Policy Institute   (United States)

^b University of California at San Diego   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conflicts of interest; Direct to consumer advertising; EHealth; Health marketing and promotion; Health policy; Physician payments; Sunshine act

Indexed keywords

ADVERTISING; CONFLICT OF INTEREST; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; PHYSICIAN; UNITED STATES;

ADVERTISING AS TOPIC; CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; HEALTH POLICY; HUMANS; MARKETING OF HEALTH SERVICES; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; UNITED STATES;

EID: 84920991599     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1711     Document Type: Article

References (22)

1. Pew Research Internet Project. Health Fact Sheet. http://www.pewinternet.org/fact-sheets/health-fact-sheet/. Published 2013. Accessed Apr 29, 2014.
2. Mackey TK, Liang BA. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Global Health. 2013;9(1):45.
3. Liang BA, Mackey TK. Prevalence and Global Health implications of social media in direct-to-consumer drug advertising. J Med Internet Res. 2011;13(3):e64.
4. Liang BA, Mackey T. Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. JAMA. 2011;305(8):824-825.
5. IMS Institute for Healthcare Informatics. Engaging Patients Through Social Media. http://www.imshealth.com/deployedfles/imshealth/ Global/Content/Corporate/IMS%20Health%20Institute/Reports/ Secure/IIHI_Social_Media_Report_2014.pdf. Published Jan 2014.
6. Collier R. Patient engagement or social media marketing? CMAJ. 2014;186(8):E237-E238.
7. Palumbo FB, Mullins CD. The development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J. 2002;57(3):423-443.
8. Liang BA, Mackey T. Reforming direct-to-consumer advertising. Nat Biotechnol. 2011;29(5):397-400.
9. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007; 357(7):673-681.
10. Kravitz RL, Bell RA. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward. Clin Pharmacol Ther. 2007;82(4):360-362.
11. Kornfeld R, Donohue J, Berndt ER, Alexander GC. Promotion of Prescription Drugs to Consumers and Providers, 2001–2010. PLoS One. 2013;8(3):e55504. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0055504. Published Mar 4, 2013.
12. Harrison C. Patent watch: the patent cliff steepens. Nat Rev Drug Discov. 2011;10 (1):12-13.
13. Calabrese M, Migliorini M. 2010 Direct-To-Consumer Industry Check-up. http://crm.cegedim.com/Docs_Whitepaper/Marketing/DTC_Survey_Whitepaper_June_2010.pdf. Published Jun 2010. Accessed Sep 23, 2013.
14. Waxman HA. The lessons of Vioxx—drug safety and sales. N Engl J Med. 2005;352(25):2576-2578.
15. Gagnon M-A, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5(1):e1. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0050001. Published Jan 3, 2008.
16. Mackey TK, Liang BA. Physician payment disclosure under health care reform: will the sun shine? J Am Board Fam Med. 2013;26(3):327-331.
17. Fugh-Berman A, Ahari S. Following the Script: How Drug Reps Make Friends and Influence Doctors. PLoS Med. 2007;4(4):e150. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0040150. Published Apr 24, 2007.
18. Wilson D. Drug App Comes Free, Ads Included. New York Times. July 29, 2011:B1. http://www.nytimes.com/2011/07/29/business/the-epocrates-app-provides-drug-information-and-drug-ads.html?pagewanted=all&_r=0. Accessed Jul 24, 2014.
19. Mackey TK, Yagi N, Liang BA. Prescription drug coupons: evolution and need for regulation in direct-to-consumer advertising. Res Social Adm Pharm. 2014;10 (3): 588-594.
20. Wang B, Kesselheim AS. The role of direct-to-consumer pharmaceutical advertising in patient consumerism. Virtual Mentor. 2013;15 (11): 960-965.
21. Osborn J. FDA Draft Guidance Takes the “Social” Out Of Social Meda. Forbes. http://www.forbes.com/sites/johnosborn/2014/05/13/fda-draft-guidance-takes-the-social-out-of-social-media/. Published May 3, 2014. Accessed Jun 2, 2014.
22. Mackey TK, Liang BA. Transparency in Physician-Industry Relationships: State and Federal Efforts. Pathol Case Rev. 2012;17(4):144-147.